PRESS RELEASE published on 05/28/2024 at 14:30, 5 months 13 days ago Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency Napo Pharmaceuticals Crofelemer Functional Diarrhea Plant-based Prescription Drug Abdominal Pain
BRIEF published on 05/23/2024 at 14:35, 5 months 18 days ago Jaguar Health présentera Gelclair pour le traitement de la mucite buccale lors de la réunion annuelle de l'ASCO Santé Jaguar Gelclair Mucite Buccale Soins De Soutien Contre Le Cancer Réunion Annuelle De L'ASCO
BRIEF published on 05/23/2024 at 14:35, 5 months 18 days ago Jaguar Health to Showcase Gelclair for Oral Mucositis at ASCO Annual Meeting Jaguar Health Gelclair Oral Mucositis Cancer Supportive Care ASCO Annual Meeting
PRESS RELEASE published on 05/23/2024 at 14:30, 5 months 18 days ago Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product Jaguar Health, Inc. announces commercial launch at ASCO Annual Meeting for Gelclair, FDA-approved oral mucositis product. Focus on cancer supportive care with phase 3 OnTarget trial results impending Jaguar Health Phase 3 Trial Gelclair Oral Mucositis ASCO Annual Meeting
BRIEF published on 05/17/2024 at 22:20, 5 months 23 days ago Jaguar Health, Inc. annonce un regroupement d'actions Investisseurs Institutionnels Conformité NASDAQ Ajustement Des Stocks Regroupement Inversé Des Actions Jaguar Santé Inc.
BRIEF published on 05/17/2024 at 22:20, 5 months 23 days ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health Inc Reverse Stock Split Nasdaq Compliance Institutional Investors Stock Adjustment
PRESS RELEASE published on 05/17/2024 at 22:15, 5 months 23 days ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health announces reverse split approval at Special Meeting of Stockholders to boost Nasdaq compliance. Stock trading on split-adjusted basis from May 23, 2024. Details in SEC filing Stockholders Meeting Jaguar Health Nasdaq Compliance Reverse Split SEC Filing
BRIEF published on 05/14/2024 at 14:05, 5 months 27 days ago Jaguar Health publie ses résultats financiers du premier trimestre 2024 Résultats Financiers Crofelemer Santé Jaguar T1 2024 Gelclair
BRIEF published on 05/14/2024 at 14:05, 5 months 27 days ago Jaguar Health Reports First Quarter 2024 Financial Results Financial Results Crofelemer Jaguar Health Q1 2024 Gelclair
PRESS RELEASE published on 05/14/2024 at 14:00, 5 months 27 days ago Jaguar Health Reports First Quarter 2024 Financial Results Jaguar Health, Inc. reports Q1 2024 financial results, with revenue increasing 20% over Q1 2023. Key updates include OnTarget trial progress and Gelclair® commercial launch plans Financial Results Jaguar Health Q1 2024 OnTarget Trial Gelclair
Published on 11/10/2024 at 02:00, 13 hours 2 minutes ago Spey Resources Corp. enters into Share Exchange Agreement with Antimony Assets and announces Name Change
Published on 11/09/2024 at 16:30, 22 hours 32 minutes ago New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Published on 11/09/2024 at 04:00, 1 day 11 hours ago Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Published on 11/08/2024 at 23:05, 1 day 15 hours ago Murchison Minerals Announces Non-Brokered Private Placement
Published on 11/10/2024 at 13:20, 1 hour 41 minutes ago EQS-Adhoc: Delivery Hero SE decides on the intended IPO of Talabat Holding plc and plans to use proceeds for general corporate purposes and capital structure optimisation
Published on 11/08/2024 at 18:35, 1 day 20 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 1 day 20 hours ago ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:02, 1 day 20 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 1 day 21 hours ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 11/08/2024 at 18:00, 1 day 21 hours ago Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 1 day 21 hours ago Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:45, 1 day 21 hours ago CHARGEURS - Voting rights monthly statement as of October 31st, 2024